Eldecalcitol: newly developed active vitamin D₃ analog for the treatment of osteoporosis

By Hagino Hiroshi  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 817-825

Informa Healthcare

Access to resources Recommend Favorite

Evaluating a newly developed pharmacogenetic array: screening in a Spanish population

By Almoguera Berta   Riveiro-Alvarez Rosa   Gomez-Dominguez Belen   Lopez-Rodriguez Rosario   Dorado Pedro   Vaquero-Lorenzo Concepción   Dal-Ré Rafael   Fernandez-Piqueras Jose   LLerena Adrián   Abad-Santos Francisco   Ayuso Carmen  

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1619-1625

Future Medicine

Access to resources Recommend Favorite

Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice

By Wu W.-R.   Zheng J.-W.   Li N.   Bai H.-Q.   Zhang K.-R.   Li Y.  

European Journal of Pharmacology, Vol. 366, Iss. 2, 1999-02 ,pp. : 261-269

Elsevier

Access to resources Recommend Favorite

Potent reinforcing effects of dihydroetorphine in rats

By Martin T.J.   Kim S.A.   Harris L.S.   Smith J.E.  

European Journal of Pharmacology, Vol. 324, Iss. 2, 1997-04 ,pp. : 141-145

Elsevier

Access to resources Recommend Favorite

Antinociceptive effect of dihydroetorphine in diabetic mice

By Kamei J.   Suzuki T.   Misawa M.   Nagase H.   Kasuya Y.  

European Journal of Pharmacology, Vol. 275, Iss. 1, 1995-02 ,pp. : 109-113

Elsevier

Access to resources Recommend Favorite